Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


May 30, 2015 3:53 PM ET

Capital Markets

Company Overview of MPM Capital

Company Overview

MPM Capital is a private equity and venture capital firm specializing in seed, startup, early ventures, emerging growth, middle market, mature, mid venture, late venture, buyout, recapitalization, PIPES, and growth equity investments. The firm makes its venture investments through its MPM BioVentures fund and invests in the public markets through MPM BioEquities hedge fund. It invests in growth stage in in the biotechnology, healthcare, and life sciences sector. It invests in the seed stage through early clinical development stage of a company and invests in late stage in biopharmaceutical and diagnostics companies with clinical proof-of-concept data. It prefers to invest in medical technolo...

450 Kendall Street

Cambridge, MA 02142

United States

Founded in 1996

Phone:

617-425-9200

Fax:

617-425-9201

Key Executives for MPM Capital

Managing Director and Managing Partner
Age: 51
Managing Director
Age: 56
Chief Financial Officer
Chief Operating Officer and General Counsel
Managing Director
Age: 42
Compensation as of Fiscal Year 2014.

MPM Capital Key Developments

MPM Capital Appoints Pablo J. Cagnoni, M.D. as Managing Director

MPM Capital announced the appointment of former President of Onyx Pharmaceuticals Pablo J. Cagnoni, M.D. as Managing Director (MD). In addition to serving as an MPM MD, Dr. Cagnoni is a co-founder of Vesuvius, an MPM-founded cancer immunotherapy company, and has taken on the role of President and Chief Executive Officer. Over of the course of his career as an oncologist and pharmaceutical executive, Dr. Cagnoni has been committed to advancing the development of breakthrough treatments for patients with cancer and other debilitating diseases. He has played a key role in the development, approval and/or commercialization of several life-changing medicines, including Afinitor®, Blinctyo®, Exjade®, Folotyn®, Glivec®, Jakavi®, Kyprolis®, Signifor®, Tarceva® and Tasigna®, among them.

MPM Capital Appoints Gregory Sieczkiewicz as Managing Director and Chief Counsel of Intellectual Property

MPM Capital announced the appointment of Gregory Sieczkiewicz as Managing Director and Chief Counsel, Intellectual Property, effective immediately. Greg will also provide IP counsel to MPM and serve as start-up IP counsel to MPM portfolio companies. In his most recent role, Greg served as Vice President, Intellectual Property, Flagship Ventures where, among other accomplishments, Greg drove the issuance of first-in-field US patents for oral biologics and served as the IP architect and co-inventor of nucleic acid therapeutics patent estate.

MPM Capital Appoints Anthony (Tony) Rosenberg as Managing Director, Effective Immediately

MPM Capital announced the appointment of long-time Novartis M&A and Licensing executive Anthony (Tony) Rosenberg as Managing Director, effective immediately. Tony will serve as a strategic advisor and board member to MPM portfolio companies, advancing MPM's proven strategy of identifying promising assets and assembling teams to build commercially successful companies.

Similar Private Companies By Industry

Company Name Region
HVB Capital LLC I United States
Marketaction, Inc. United States
Bonner Business Center United States
InterOcean Financial Group LLC United States
Allco Finance Group Limited (United States) United States

Recent Private Companies Transactions

Type
Date
Target
Private Placement
April 7, 2015
True North Therapeutics, Inc.
Private Placement
March 18, 2015
Clinical Ink, Inc.
Private Placement
March 18, 2015
Semma Therapeutics, Inc.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Bertelsmann AG Europe
Rush University United States
Greater Houston Partnership United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact MPM Capital, please visit www.mpmcapital.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.